August Bioservices is a US-based CDMO offering end-to-end drug development and manufacturing from pre-clinical to commercial. It combines large-CDMO scale with a customer-focused hybrid model to serve startups and big pharma. It provides full development programs including research, development, testing, lab services, and sterile fill/finish under one integrated process, ensuring cGMP and FDA-quality standards. Its goal is to help clients bring safe, effective drugs to market efficiently through a seamless, integrated pathway.
Company Size
51-200
Company Stage
Series B
Total Funding
$88.6M
Headquarters
Nashville, Tennessee
Founded
2017
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?